1. A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS. Issue 3 (3rd April 2021) Authors: Shefner, Jeremy M.; Andrews, Jinsy A.; Genge, Angela; Jackson, Carlayne; Lechtzin, Noah; Miller, Timothy M.; Cockroft, Bettina M.; Meng, Lisa; Wei, Jenny; Wolff, Andrew A.; Malik, Fady I.; Bodkin, Cynthia; Brooks, Benjamin R.; Caress, James; Dionne, Annie; Fee, Dominic; Goutman, Stephen A.; Goyal... Journal: Amyotrophic lateral sclerosis and frontotemporal degeneration Issue: Volume 22:Issue 3/4(2021) Page Start: 287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Burden of influenza in adults with cardiac arrest admissions in Australia. (15th August 2022) Authors: Moa, Aye; Tan, Timothy; Wei, Jenny; Hutchinson, Danielle; MacIntyre, C. Raina Journal: International journal of cardiology Issue: Volume 361(2022) Page Start: 109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Epigenetic plasticity potentiates a rapid cyclical shift to and from an aggressive cancer phenotype. Issue 11 (22nd February 2020) Authors: Xu, Tong; Li, Hong‐Tao; Wei, Jenny; Li, Meng; Hsieh, Tien‐Chan; Lu, Yi‐Tsung; Lakshminarasimhan, Ranjani; Xu, Rong; Hodara, Emmanuelle; Morrison, Gareth; Gujar, Hemant; Rhie, Suhn Kyong; Siegmund, Kimberly; Liang, Gangning; Goldkorn, Amir Journal: International journal of cancer Issue: Volume 146:Issue 11(2020) Page Start: 3065 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving reldesemtiv or placebo in FORTITUDE-ALS. (31st December 2023) Authors: Gebrehiwet, Paulos; Meng, Lisa; Rudnicki, Stacy A.; Sarocco, Phil; Wei, Jenny; Wolff, Andrew A.; Butzner, Michael; Chiò, Adriano; Andrews, Jinsy A.; Genge, Angela; Hughes, Dyfrig A.; Jackson, Carlayne E.; Lechtzin, Noah; Miller, Timothy M.; Shefner, Jeremy M. Journal: Journal of medical economics Issue: Volume 26:Number 1(2023) Page Start: 488 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. MiToS and King's staging as clinical outcome measures in ALS: a retrospective analysis of the FORTITUDE-ALS trial. Issue 3 (3rd April 2023) Authors: Gebrehiwet, Paulos; Meng, Lisa; Rudnicki, Stacy A.; Sarocco, Phil; Wei, Jenny; Wolff, Andrew A.; Chiò, Adriano; Andrews, Jinsy A.; Genge, Angela; Jackson, Carlayne E.; Lechtzin, Noah; Miller, Timothy M.; Shefner, Jeremy M. Journal: Amyotrophic lateral sclerosis and frontotemporal degeneration Issue: Volume 24:Issue 3/4(2023) Page Start: 304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Prescription and acceptance of durable medical equipment in FORTITUDE-ALS, a study of reldesemtiv in ALS: post hoc analyses of a randomized, double-blind, placebo-controlled clinical trial. Issue 3 (3rd April 2022) Authors: Rudnicki, Stacy A.; Andrews, Jinsy A.; Genge, Angela; Jackson, Carlayne; Lechtzin, Noah; Miller, Timothy M.; Cockroft, Bettina M.; Malik, Fady I.; Meng, Lisa; Wei, Jenny; Wolff, Andrew A.; Shefner, Jeremy M. Journal: Amyotrophic lateral sclerosis and frontotemporal degeneration Issue: Volume 23:Issue 3/4(2022) Page Start: 263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Relationships between slow vital capacity and measures of respiratory function on the ALSFRS-R. Issue 7 (2nd October 2018) Authors: Jackson, Carlayne; De Carvalho, Mamede; Genge, Angela; Heiman-Patterson, Terry; Shefner, Jeremy M.; Wei, Jenny; Wolff, Andrew A. Journal: Amyotrophic lateral sclerosis and frontotemporal degeneration Issue: Volume 19:Issue 7/8(2018) Page Start: 506 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma: High Rates of Local Control With Low Toxicity. (November 2018) Authors: Baumann, Brian C.; Wei, Jenny; Plastaras, John P.; Lukens, John N.; Damjanov, Nevena; Hoteit, Maarouf; Hsu, Christine; Levine, Matthew; Mondschein, Jeffrey; Nadolski, Gregory; Olthoff, Kim; Reiss, Kim A.; Rosen, Mark; Siegelman, Evan; Metz, James M.; Ben-Josef, Edgar Journal: American journal of clinical oncology Issue: Volume 41:Number 11(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗